News

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...
For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in ...
Lakeshore Bone and Joint Institute has been selected as one of the 45 U.S. sites for a new clinical study evaluating the use of mesenchymal precursor cells (a type of stem cells) in subjects with ...
Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...
A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...
The NHS is to trial “robo minders” to keep an eye on dementia patients in their own homes. The technology will allow hospital ...
Dr. Hussein Tawbi, who works for MD Anderson in Houston, said there are two things he hopes people take away from the story ...
Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.
In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...